Obermatt
See Similar Stocks →

Boston Scientific

NYQ:BSX · US1011371077
Health Care Equipment & SuppliesXX-Large

360

75
EV / EBIT71
Price / Owner Earnings65
Owner Earnings Yield89
Dividend Yield1
Price/Sales49
EV / Gross Profit47
Price/Book51
Return on Capital51
Cash Return on Capital75
Return on Equity67
EBIT Margin72
Gross Profitability40
Cash Conversion11
Accruals25
Owner Earnings Margin89
Sales growth44
Profit Growth93
Long-Term EPS Growth73
Owner Earnings Growth86
Reinvestment30
Price momentum10
Debt load55
Refinancing48
Debt Payback51
Liquidity82
Analyst ratings50
Opinion Changes32
Price Target Upside100
Market mood98
Value Creation20/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Boston Scientific generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeXX-Large
TypePublic Company
ExchangeNYSE
Founded1979
Employees38,619
Websitebostonscientific.com/en-US/Home.html
ISINUS1011371077
Last UpdateApr 2, 2026
Indices
Renewable Energy UsersS&P 500 (USA)D.J. US Health CareD.J. US Medical Equipment
Themes
CardiovascularPain ManagementHealth DiagnosticsUrologyBiomedical EngineeringGastroenterologyOncologySurgeryNeurologyHealth CareMedicalMedical Device

Description

Boston Scientific Corporation operates as a global developer, manufacturer, and marketer of medical devices that are used in a broad range of interventional medical specialties. As a medical technology leader, the company has advanced the practice o…

Analysis

Middle-of-the-road

Boston Scientific Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is fair. The owner-earnings multiple stands at 17.1×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 4% a year, against analyst forecasts of 15%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is sturdy. The company scores 20/20 on our value-creation score: strong value creator.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
66
2023202420252026

All-time high

74

Jan 2025

All-time low

42

Jan 2023

Average rank

62

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
49
9
26
52
Price/Earnings
43
19
42
67
Price/Book
51
24
36
64
Dividend Yield
1
1
1
1
Value (overall)
38
20
8
19

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Boston Scientific with its peers
Integer
NYQ:ITGR
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Microbot Medical
NAQ:MBOT
16
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →
Globus Medical
NYQ:GMED
98
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Teleflex
NYQ:TFX
5
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Profound Medical
TOR:PRN
29
CountryCanada
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
PROCEPT BioRobotics
NMQ:PRCT
19
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →